195 related articles for article (PubMed ID: 6135740)
1. Biochemical and pharmacological differentiation of neuroleptic effect on dopamine D-1 and D-2 receptors.
Hyttel J; Christensen AV
J Neural Transm Suppl; 1983; 18():157-64. PubMed ID: 6135740
[TBL] [Abstract][Full Text] [Related]
2. Behavioural correlates to the dopamine D-1 and D-2 antagonists.
Christensen AV; Arnt J; Hyttel J; Svendsen O
Pol J Pharmacol Pharm; 1984; 36(2-3):249-64. PubMed ID: 6147830
[TBL] [Abstract][Full Text] [Related]
3. Changes in apomorphine-induced stereotypy as a result of subacute neuroleptic treatment correlates with increased D-2 receptors, but not with increases in D-1 receptors.
Fleminger S; Rupniak NM; Hall MD; Jenner P; Marsden CD
Biochem Pharmacol; 1983 Oct; 32(19):2921-7. PubMed ID: 6138043
[TBL] [Abstract][Full Text] [Related]
4. Assay of dopamine receptors with [alpha-3H]flupenthixol.
Huff RM; Molinoff PB
J Pharmacol Exp Ther; 1985 Jan; 232(1):57-61. PubMed ID: 3965700
[TBL] [Abstract][Full Text] [Related]
5. Effects of neuroleptics on 3H-haloperidol and 3H-cis(Z)-flupenthixol binding and on adenylate cyclase activity in vitro.
Hyttel J
Life Sci; 1978 Aug; 23(6):551-5. PubMed ID: 29194
[No Abstract] [Full Text] [Related]
6. Inactivation of D1 and D2 dopamine receptors by N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline in vivo: selective protection by neuroleptics.
Meller E; Bohmaker K; Goldstein M; Friedhoff AJ
J Pharmacol Exp Ther; 1985 Jun; 233(3):656-62. PubMed ID: 2861276
[TBL] [Abstract][Full Text] [Related]
7. Specific [3H]piflutixol binding to CHAPS-solubilised rat striatal preparations involves dopamine D-2 but not D-1 binding sites.
Kilpatrick GJ; Jenner P; Marsden CD
J Neurochem; 1986 Feb; 46(2):413-21. PubMed ID: 3941314
[TBL] [Abstract][Full Text] [Related]
8. Further evidence that 3H-cis(Z)flupenthixol binds to the adenylate cyclase-associated dopamine receptor (D-1) in rat corpus striatum.
Hyttel J
Psychopharmacology (Berl); 1980 Jan; 67(1):107-9. PubMed ID: 6768074
[TBL] [Abstract][Full Text] [Related]
9. Pharmacological differentiation of dopamine D-1 and D-2 antagonists after single and repeated administration.
Christensen AV; Arnt J; Svendsen O
Psychopharmacology Suppl; 1985; 2():182-90. PubMed ID: 2860659
[TBL] [Abstract][Full Text] [Related]
10. Alterations in different populations of striatal dopamine receptors produced by 18 months continuous administration of cis- or trans-flupenthixol to rats.
Murugaiah K; Fleminger S; Hall MD; Theodorou A; Jenner P; Marsden CD
Neuropharmacology; 1984 Jun; 23(6):599-609. PubMed ID: 6540376
[TBL] [Abstract][Full Text] [Related]
11. Long-term adaptive changes in striatal dopamine function in response to chronic neuroleptic intake in rats.
Jenner P; Kerwin R; Rupniak NM; Murugaiah K; Hall MD; Fleminger S; Marsden CD
J Neural Transm Suppl; 1983; 18():205-12. PubMed ID: 6135741
[TBL] [Abstract][Full Text] [Related]
12. [The affinity of aromatic fluoride derivatives of phenothiazine neuroleptics to spiroperidol binding sites of dopamine receptors by the radioligand technic in vitro].
Oelssner W; Peinhardt G; Büge A
Pharmazie; 1985 May; 40(5):341-2. PubMed ID: 2863832
[TBL] [Abstract][Full Text] [Related]
13. Similarities between the binding of 3H-piflutixol and 3H-flupentixol to rat striatal dopamine receptors in vitro.
Hyttel J
Life Sci; 1981 Feb; 28(5):563-9. PubMed ID: 6111013
[No Abstract] [Full Text] [Related]
14. Kainic acid lesions dissociate [3H] spiperone and [3H]cis-flupenthixol binding sites in rat striatum.
Cross AJ; Waddington JL
Eur J Pharmacol; 1981 May; 71(2-3):327-32. PubMed ID: 7250192
[TBL] [Abstract][Full Text] [Related]
15. Receptor pharmacology. Its use in neuroleptic research.
Hyttel J
Acta Psychiatr Belg; 1987; 87(5):535-51. PubMed ID: 2897759
[TBL] [Abstract][Full Text] [Related]
16. Pharmacological effects of a specific dopamine D-1 antagonist SCH 23390 in comparison with neuroleptics.
Christensen AV; Arnt J; Hyttel J; Larsen JJ; Svendsen O
Life Sci; 1984 Apr; 34(16):1529-40. PubMed ID: 6144029
[TBL] [Abstract][Full Text] [Related]
17. Irreversible interaction of beta-haloalkylamine derivatives with dopamine D1 and D2 receptors.
Cross AJ; Waddington JL; Ross ST
Life Sci; 1983 Jun; 32(24):2733-40. PubMed ID: 6222234
[TBL] [Abstract][Full Text] [Related]
18. Phenoxybenzamine treatment differentiates dopaminergic 3H-ligand binding sites in bovine caudate membranes.
Hamblin MW; Creese I
Mol Pharmacol; 1982 Jan; 21(1):44-51. PubMed ID: 6127621
[TBL] [Abstract][Full Text] [Related]
19. Antipsychotic drug effects on dopamine and serotonin receptors: in vitro binding and in vivo turnover studies.
Bacopoulos NG
J Pharmacol Exp Ther; 1981 Dec; 219(3):708-14. PubMed ID: 6170752
[TBL] [Abstract][Full Text] [Related]
20. [Stimulation by cerulein--an analog of the octapeptide cholecystokinin--of 3H-spiroperidol binding after the long-term administration of neuroleptics].
Vasar EE; Nurk AM; Maĭmets MO; Allikmets LKh
Biull Eksp Biol Med; 1985 Jan; 99(1):72-4. PubMed ID: 2857100
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
